Logo image of CRUS

CIRRUS LOGIC INC (CRUS) Stock Fundamental Analysis

NASDAQ:CRUS - US1727551004 - Common Stock

116.01 USD
-1.37 (-1.17%)
Last: 8/25/2025, 8:12:38 PM
116.09 USD
+0.08 (+0.07%)
After Hours: 8/25/2025, 8:12:38 PM
Fundamental Rating

7

Overall CRUS gets a fundamental rating of 7 out of 10. We evaluated CRUS against 110 industry peers in the Semiconductors & Semiconductor Equipment industry. Both the health and profitability get an excellent rating, making CRUS a very profitable company, without any liquidiy or solvency issues. CRUS has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year CRUS was profitable.
In the past year CRUS had a positive cash flow from operations.
Each year in the past 5 years CRUS has been profitable.
In the past 5 years CRUS always reported a positive cash flow from operatings.
CRUS Yearly Net Income VS EBIT VS OCF VS FCFCRUS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

1.2 Ratios

CRUS has a better Return On Assets (14.25%) than 87.27% of its industry peers.
With an excellent Return On Equity value of 17.01%, CRUS belongs to the best of the industry, outperforming 83.64% of the companies in the same industry.
The Return On Invested Capital of CRUS (14.43%) is better than 87.27% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CRUS is above the industry average of 10.98%.
The 3 year average ROIC (13.70%) for CRUS is below the current ROIC(14.43%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 14.25%
ROE 17.01%
ROIC 14.43%
ROA(3y)11.7%
ROA(5y)12.47%
ROE(3y)14.26%
ROE(5y)15.76%
ROIC(3y)13.7%
ROIC(5y)13.38%
CRUS Yearly ROA, ROE, ROICCRUS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

1.3 Margins

Looking at the Profit Margin, with a value of 17.48%, CRUS is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
In the last couple of years the Profit Margin of CRUS has grown nicely.
Looking at the Operating Margin, with a value of 21.64%, CRUS is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
CRUS's Operating Margin has improved in the last couple of years.
CRUS's Gross Margin of 52.53% is fine compared to the rest of the industry. CRUS outperforms 68.18% of its industry peers.
CRUS's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 21.64%
PM (TTM) 17.48%
GM 52.53%
OM growth 3Y1.72%
OM growth 5Y7.25%
PM growth 3Y-1.55%
PM growth 5Y7.03%
GM growth 3Y0.44%
GM growth 5Y-0.04%
CRUS Yearly Profit, Operating, Gross MarginsCRUS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40 50

10

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CRUS is still creating some value.
Compared to 1 year ago, CRUS has less shares outstanding
The number of shares outstanding for CRUS has been reduced compared to 5 years ago.
There is no outstanding debt for CRUS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CRUS Yearly Shares OutstandingCRUS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
CRUS Yearly Total Debt VS Total AssetsCRUS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.2 Solvency

An Altman-Z score of 11.56 indicates that CRUS is not in any danger for bankruptcy at the moment.
The Altman-Z score of CRUS (11.56) is better than 81.82% of its industry peers.
There is no outstanding debt for CRUS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 11.56
ROIC/WACC1.23
WACC11.7%
CRUS Yearly LT Debt VS Equity VS FCFCRUS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.3 Liquidity

CRUS has a Current Ratio of 6.35. This indicates that CRUS is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 6.35, CRUS belongs to the top of the industry, outperforming 85.45% of the companies in the same industry.
CRUS has a Quick Ratio of 4.82. This indicates that CRUS is financially healthy and has no problem in meeting its short term obligations.
CRUS has a Quick ratio of 4.82. This is amongst the best in the industry. CRUS outperforms 81.82% of its industry peers.
Industry RankSector Rank
Current Ratio 6.35
Quick Ratio 4.82
CRUS Yearly Current Assets VS Current LiabilitesCRUS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 12.62% over the past year.
CRUS shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 13.60% yearly.
Looking at the last year, CRUS shows a small growth in Revenue. The Revenue has grown by 5.99% in the last year.
Measured over the past years, CRUS shows a quite strong growth in Revenue. The Revenue has been growing by 8.16% on average per year.
EPS 1Y (TTM)12.62%
EPS 3Y3%
EPS 5Y13.6%
EPS Q2Q%34.82%
Revenue 1Y (TTM)5.99%
Revenue growth 3Y2.1%
Revenue growth 5Y8.16%
Sales Q2Q%8.89%

3.2 Future

Based on estimates for the next years, CRUS will show a decrease in Earnings Per Share. The EPS will decrease by -1.19% on average per year.
The Revenue is expected to grow by 0.75% on average over the next years.
EPS Next Y-3.02%
EPS Next 2Y0.97%
EPS Next 3Y-1.19%
EPS Next 5YN/A
Revenue Next Year-0.32%
Revenue Next 2Y3.05%
Revenue Next 3Y0.75%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CRUS Yearly Revenue VS EstimatesCRUS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B 2B
CRUS Yearly EPS VS EstimatesCRUS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6

6

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 14.61, the valuation of CRUS can be described as correct.
Compared to the rest of the industry, the Price/Earnings ratio of CRUS indicates a rather cheap valuation: CRUS is cheaper than 90.91% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 27.03. CRUS is valued slightly cheaper when compared to this.
With a Price/Forward Earnings ratio of 15.07, CRUS is valued correctly.
CRUS's Price/Forward Earnings ratio is rather cheap when compared to the industry. CRUS is cheaper than 89.09% of the companies in the same industry.
CRUS's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.63.
Industry RankSector Rank
PE 14.61
Fwd PE 15.07
CRUS Price Earnings VS Forward Price EarningsCRUS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

84.55% of the companies in the same industry are more expensive than CRUS, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, CRUS is valued cheaply inside the industry as 91.82% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 14.33
EV/EBITDA 11.65
CRUS Per share dataCRUS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

CRUS has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)1.07
EPS Next 2Y0.97%
EPS Next 3Y-1.19%

0

5. Dividend

5.1 Amount

No dividends for CRUS!.
Industry RankSector Rank
Dividend Yield N/A

CIRRUS LOGIC INC

NASDAQ:CRUS (8/25/2025, 8:12:38 PM)

After market: 116.09 +0.08 (+0.07%)

116.01

-1.37 (-1.17%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)08-05 2025-08-05/amc
Earnings (Next)11-03 2025-11-03/amc
Inst Owners98.94%
Inst Owner Change-1.91%
Ins Owners0.49%
Ins Owner Change8.35%
Market Cap5.95B
Analysts81.43
Price Target125.65 (8.31%)
Short Float %3.6%
Short Ratio3.41
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)27.4%
Min EPS beat(2)15.88%
Max EPS beat(2)38.92%
EPS beat(4)4
Avg EPS beat(4)35.66%
Min EPS beat(4)9.26%
Max EPS beat(4)78.58%
EPS beat(8)8
Avg EPS beat(8)43.51%
EPS beat(12)12
Avg EPS beat(12)36.88%
EPS beat(16)16
Avg EPS beat(16)33.94%
Revenue beat(2)2
Avg Revenue beat(2)8.09%
Min Revenue beat(2)6.77%
Max Revenue beat(2)9.42%
Revenue beat(4)4
Avg Revenue beat(4)8.33%
Min Revenue beat(4)2.07%
Max Revenue beat(4)15.06%
Revenue beat(8)8
Avg Revenue beat(8)9.02%
Revenue beat(12)11
Avg Revenue beat(12)8.14%
Revenue beat(16)15
Avg Revenue beat(16)7.65%
PT rev (1m)0%
PT rev (3m)2.13%
EPS NQ rev (1m)0%
EPS NQ rev (3m)1.86%
EPS NY rev (1m)1.61%
EPS NY rev (3m)2.07%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.62%
Revenue NY rev (1m)0.05%
Revenue NY rev (3m)0.37%
Valuation
Industry RankSector Rank
PE 14.61
Fwd PE 15.07
P/S 3.14
P/FCF 14.33
P/OCF 13.4
P/B 3.05
P/tB 4.01
EV/EBITDA 11.65
EPS(TTM)7.94
EY6.84%
EPS(NY)7.7
Fwd EY6.63%
FCF(TTM)8.1
FCFY6.98%
OCF(TTM)8.66
OCFY7.46%
SpS36.94
BVpS37.98
TBVpS28.95
PEG (NY)N/A
PEG (5Y)1.07
Profitability
Industry RankSector Rank
ROA 14.25%
ROE 17.01%
ROCE 19.25%
ROIC 14.43%
ROICexc 20.03%
ROICexgc 28.68%
OM 21.64%
PM (TTM) 17.48%
GM 52.53%
FCFM 21.92%
ROA(3y)11.7%
ROA(5y)12.47%
ROE(3y)14.26%
ROE(5y)15.76%
ROIC(3y)13.7%
ROIC(5y)13.38%
ROICexc(3y)18.68%
ROICexc(5y)18.11%
ROICexgc(3y)27.43%
ROICexgc(5y)27.07%
ROCE(3y)18.28%
ROCE(5y)17.85%
ROICexcg growth 3Y-2.62%
ROICexcg growth 5Y9.35%
ROICexc growth 3Y2.54%
ROICexc growth 5Y8.89%
OM growth 3Y1.72%
OM growth 5Y7.25%
PM growth 3Y-1.55%
PM growth 5Y7.03%
GM growth 3Y0.44%
GM growth 5Y-0.04%
F-Score9
Asset Turnover0.81
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 56.43%
Cap/Sales 1.52%
Interest Coverage 1015.74
Cash Conversion 96.33%
Profit Quality 125.37%
Current Ratio 6.35
Quick Ratio 4.82
Altman-Z 11.56
F-Score9
WACC11.7%
ROIC/WACC1.23
Cap/Depr(3y)62.46%
Cap/Depr(5y)55.84%
Cap/Sales(3y)1.86%
Cap/Sales(5y)1.76%
Profit Quality(3y)145.47%
Profit Quality(5y)123.32%
High Growth Momentum
Growth
EPS 1Y (TTM)12.62%
EPS 3Y3%
EPS 5Y13.6%
EPS Q2Q%34.82%
EPS Next Y-3.02%
EPS Next 2Y0.97%
EPS Next 3Y-1.19%
EPS Next 5YN/A
Revenue 1Y (TTM)5.99%
Revenue growth 3Y2.1%
Revenue growth 5Y8.16%
Sales Q2Q%8.89%
Revenue Next Year-0.32%
Revenue Next 2Y3.05%
Revenue Next 3Y0.75%
Revenue Next 5YN/A
EBIT growth 1Y18.82%
EBIT growth 3Y3.86%
EBIT growth 5Y16%
EBIT Next Year16.13%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y8.42%
FCF growth 3Y63.67%
FCF growth 5Y8.67%
OCF growth 1Y5.38%
OCF growth 3Y52.7%
OCF growth 5Y8.48%